BSTC Financial Facts

Total Revenues: 4.07M
Licensing revenues: 2.02M
See Full Income Statement

Deferred revenue: 69.13K
Long-term deferred revenue: 138.26K
See Full Balance Sheet

BioSpecifics Technologies Corp. (BSTC) Earnings

  |   Expand Research on BSTC
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate +51.8% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -1.4% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
8/9/12 Q212 $0.11$0.07 +$0.04$2.6M$2.5M N/A +33% Details
3/9/12 Q411 $0.01N/A N/A $2.6M$1.1M N/A +31.1% Details
11/8/11 Q311 $0.04N/A N/A $1.9M$1M N/A +48.2% Details
3/11/11 Q410 $0.02-$0.04 +$0.06$1.1M$1.38M N/A -6.5% Details